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Control over Enzymatic Activity by DNA-Directed Split Enzyme Reassembly
Nﬄria Sancho Oltra, Jeffrey Bos, and Gerard Roelfes*[a]
Metabolic pathways are tightly regulated to control the con-
centration of metabolites in the cell. While a number of differ-
ent methods are used to achieve such regulation, perhaps the
most fascinating is control of enzyme activity through allostery,
in which binding of an effector molecule either in-
creases or decreases the catalytic activity.[1, 2] Thus,
the activity of allosteric enzymes is modulated by the
chemical composition of their environment. In recent
years, attempts have been made to design such ef-
fects in existing nonallosteric enzymes;[3] this is po-
tentially interesting for applications, such as chemical
sensors, as this provides a mechanism for signal
amplification.[4] A potentially versatile approach to
designed allosteric enzymes involves introduction of
nonproteinogenic moieties into an enzyme; these
moieties can then be used to control enzyme activi-
ty.[5] For this purpose, DNA is particularly attractive;
the highly specific base-pairing interactions can be
used to modulate enzyme activity with an exception-
al degree of control.[6] A few approaches in which
DNA hybridization has been used to control enzy-
matic activity have been reported to date; these include me-
chanical induction of conformational changes in enzymes or
peptidic ligands,[7–9] rigidification of a DNA tether between an
enzyme and a competitive inhibitor,[10] and directed assembly
of multi-enzyme systems.[11,12] Here, we present a novel ap-
proach to DNA-controlled enzymatic activity ; this involves a
split enzyme system that can be reassembled into a catalytical-
ly active conformation by hybridization of the protein-frag-
ment-conjugated oligonucleotides with a template DNA
strand.
Split proteins have emerged as versatile and attractive tools
for in vivo and in vitro sensing applications for protein–protein
interactions, protein–DNA interactions, and small-molecule
binding.[13–19] Recently, split proteins have been combined with
nonproteinogenic recognition moieties,[20] including DNA olig-
omers.[21,22] To date this has been limited to the functional,
nontemplated, recombination of fluorescent and luminescent
proteins. A similar approach has been reported for a split per-
oxidase DNAzyme.[23,24]
We envisioned that a split enzyme equipped with oligonu-
cleotides conjugated to both protein fragments, would give
rise to an artificial allosteric enzymatic system; upon binding
of a complementary external DNA strand the enzyme is reas-
sembled into an active conformation, thereby allowing cataly-
sis to occur (Figure 1). In this manner, catalytic activity can be
modulated by both the concentration and the sequence of the
external DNA strand.
The design was based on the enzyme murine dihydrofolate
reductase (mDHFR), which catalyzes the NADPH dependent re-
duction of dihydrofolate into tetrahydrofolate. mDHFR was se-
lected because it can be dissected into two fragments, which
can be recombined to give a stable protein, as has been dem-
onstrated for this and the homologous E. coli enzyme. Howev-
er, a secondary covalent or noncovalent interaction between
the two protein segments is required for catalytic activity to
be restored.[16,18, 25–27] Based on these studies, mDHFR was dis-
connected between amino acids 105 and 106 on the genetic
level.
A maleimide coupling strategy was selected for the prepara-
tion of the mDHFR fragment oligonucleotide conjugates.
This strategy requires the mDHFR fragments to be equipped
with a nucleophilic cysteine residue (Scheme 1). The two frag-
ments of mDHFR, that is, N-terminal mDHFR, corresponding to
residues 1–105 and C-terminal mDHFR, corresponding to the
106–186 fragment, were cloned and expressed independently.
A C-terminal cysteine was added on the genetic level to N-ter-
minal mDHFR along with an N-terminal His6-tag for purification
purposes. In the case of the C-terminal mDHFR fragment a C-
terminal His6-tag was included. The cysteine needed for conju-
gation was included to the N terminus as part of an MGC or
MGCGGSGG extension, to give C-terminal mDHFR (1) and C-
terminal mDHFR (2), respectively.
The mDHFR fragments were expressed in E. coli BL21 (DE3),
purified under denaturing conditions on a nickel–agarose
column, and analyzed by gel electrophoresis and ESI mass
spectrometry. In the case of the C-terminal mDHFR fragments
a mass corresponding to the loss of the N-terminal methionine
Figure 1. Schematic representation of the activation of split mDHFR by DNA hybridiza-
tion. Green corresponds to oligonucleotide 2 C-terminal mDHFR, red corresponds to oli-
gonucleotide 1 N-terminal mDHFR, and blue corresponds to the DNA template.
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was found; m/z 10694 Da for C-terminal mDHFR (1) (calcd M-
Met: 10692 Da), and 11009 for C-terminal mDHFR (2) (calcd M-
Met: 11008 Da).
16-Mer oligonucleotides were conjugated to the mDHFR
fragments, as these would provide a strong thermodynamic
driving force for the split enzyme reassembly upon hybridiza-
tion with the template DNA.
The maleimido 5’- and 3’- modified oligonucleotides were
prepared by treatment of the corresponding terminal amino-
modified oligonucleotides with 3-maleimidopropionic acid N-
hydroxysuccinimide ester (Scheme 1). The resulting maleimide
functionalized oligonucleotides were purified by size-exclusion
chromatography and analyzed by reversed-phase HPLC and
MALDI-TOF. Isolated yields were typically around 90%. The N-
terminal mDHFR and C-terminal mDHFR fragments were conju-
gated to 5’ and 3’ oligonucleotides, respectively, by maleimide
coupling (Scheme 1) under denaturing conditions to prevent
precipitation. Conversions were estimated from PAGE to be
around 70% for the N-terminal mDHFR fragment and around
10% for the C-terminal mDHFR (1) fragment. The conversion
of the conjugation of the C-terminal mDHFR (2) fragment,
which contains a GGSGG linker between the cysteine and the
start of the mDHFR fragment, was considerably higher, that is,
around 40%. This indicates that the steric hindrance of the
amino acids surrounding the reactive cysteine is important for
the effectiveness of the coupling.
The resulting protein–DNA conjugates were purified from
uncoupled mDHFR by anion-exchange chromatography on a
HiTrap QFF column. Purification from uncoupled oligonucleo-
tide was achieved by affinity chromatography on a nickel–nitri-
loacetic acid (Ni–NTA) column; this takes advantage of the His6
tags on the protein fragments. Moreover, this last step also
results in concentration of the protein–DNA conjugates. This
purification procedure gave rise to highly pure protein–DNA
conjugates, as was confirmed by PAGE and analytical size-ex-
clusion chromatography, which demonstrated that the material
was free of unconjugated DNA (see the Supporting Informa-
tion).
The catalytic activity of the system was evaluated in the
NADPH-dependent reduction of dihydrofolate into tetrahydro-
folate, by using the standard DHFR assay.[28] The system was
assembled by using a rapid dilution protocol.[29] Equimolar
amounts of the DNA conjugates of N-terminal mDHFR and C-
terminal mDHFR (2), and DNA template in 8m of urea were
premixed and diluted into the reaction buffer, and this allowed
for protein refolding and DNA hybridization to occur. The
progress of the enzymatic reaction was monitored by follow-
ing the consumption of NADPH with time by using UV–visible
measurements at 340 nm. In the absence of template DNA, no
catalytic activity was observed; the observed decrease in
NADPH absorption coincided with that found for the uncata-
lyzed NADPH degradation. When including the fully comple-
mentary DNA template in the reaction, a rapid consumption of
NADPH was observed, thereby demonstrating that the assem-
bled system indeed is catalytically active (Figure 2). A lag
phase is observed in the early stages of the reaction. Therefore,
in order to allow quantitative comparison of reaction rates, the
initial 15% of the reaction was not considered. Compared to
the wild-type mDHFR, the DNA-based system is only 2.5-fold
slower (Table 1, entries 1, 2) ; this suggests that the conforma-
tion of the reassembled enzyme closely resembles that of the
wild-type enzyme. These results clearly demonstrate that the
secondary interactions provided by the DNA template result in
the assembly of an active enzyme, and induce catalysis of the
dihydrofolate reduction.
Scheme 1. Schematic representation of the preparation of mDHFR-oligonucleotide conjugates, and the general coupling procedure between maleimide-func-
tionalized oligonucleotide and mDHFR fragments. a) 3-maleimidopropionic acid N-hydroxysuccinimide ester in DMF, phosphate buffer 200 mm pH 7.2, 2 h.
b) 2-(N-cyclohexylamino)ethane sulfonic acid (CHES) buffer 100 mm, pH 9.2, 8m urea. Oligonucleotide 1 is : aminohexyl-5’-d(GACATGTCTGACCTTG)-3’ and oli-
gonucleotide 2 is: 5’-d(GACTGGTGAGAACGCT) -3’-(2-aminoethyl-6-hexylcarbamate). Sequence of template: 5’-d(CAAGGTCAGACATGTCAGCGTTCTCACCAGTC)-
3’; residues exchanged in mismatch studies are underlined.
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The catalytic activity was found to be dependent on the
concentration of the DNA template (Table 1, entries 2–8). With
less than 1 equivalent of template with respect to N-terminal
mDHFR and C-terminal mDHFR (2) DNA conjugates, a lower ac-
tivity is observed, as expected. Maximum activity was observed
when 1 equivalent of template was used. Increasing the con-
centration of the DNA template to >1 equivalent also results
in a progressively lower activity. This is attributed to the fact
that with more than equimolar amounts of template present, a
mixture of the active reassembled system and templates hy-
bridized with only N-terminal mDHFR or C-terminal mDHFR (2)
DNA conjugates, which are not active, are formed, thereby re-
sulting in an overall decrease in activity. Moreover, experiments
in which the refolding of full-length mDHFR was performed in
the presence of free DNA showed lower activity compared to
when the DNA was absent, and this indicates that an excess of
DNA might also inhibit the enzyme.
The effect of mismatches in the DNA template on catalytic
activity was investigated. By using 1 equivalent of template, a
decrease in catalytic activity was found when the number of
mismatches was increased. Compared to the full complemen-
tary template the activity was reduced by 50% when five mis-
matches were introduced into the template at positions 12, 14,
16, 20, and 27. The observed activities with one mismatch at
position 16 or three mismatches at positions 16, 20, and 27,
were found to be similar. This is due to the fact that the three
mutations are distributed over the template with one and two
mismatches in the sequences complementary to oligonucleo-
tides 1 and 2, respectively. Hence, the observed decrease in ac-
tivity is less than would be expected with all three mutations
in the sequence complementary to oligonucleotide 1 or 2.
Combined, these results show that destabilization of the DNA
duplex results in a decrease in activity. This can be tentatively
explained by assuming that a weaker duplex results in more
structural flexibility in the protein part, and this results in less
of the protein being in the catalytically active conformation.
With the DNA-based split-enzyme systems investigated here,
a lag phase is observed before catalysis occurs efficiently. A
tentative explanation is that, upon dilution with the reaction
buffer, some time is required for the hybridization and folding
of the system into a catalytically active conformation to occur.
However, the lag phase was still observed when the system
was preincubated either in the reaction buffer or in the buffer
containing dihydrofolate for 2 h. Moreover, in these cases a
significant decrease in activity was found. Most likely, in addi-
tion to the DNA driven reassembly other interactions are re-
quired for obtaining the active conformation of the enzyme.
Based on earlier work on the homologous E. coli enzyme, it is
hypothesized that binding of both, dihydrofolate and NADPH,
is also required for folding into an active conformation.[26]
In conclusion, here we have shown that the catalytic activity
of a DNA-conjugated split enzyme, that is, mDHFR, can be
modulated by the concentration and sequence complementar-
ity of a DNA template. This represents a novel and versatile ap-
proach to artificial allosteric enzymes. Particularly attractive of
the present design is that in addition to DNA-controlled cata-
lytic activity, it is envisioned that the concept can be adapted
readily for small-molecule-dependent control over catalytic ac-
tivity, by inclusion of DNA aptamer structures in the template
DNA strand.[30]
Experimental Section
General procedure for the reduction of dihydrofolate catalyzed
by the split mDHFR system : A solution of equimolar amounts of
DNA template, N-terminal mDHFR and C-terminal mDHFR- oligonu-
cleotide conjugates in buffer (100 mm NaH2PO4, pH 4, 100 mm Tris-
Figure 2. Kinetic curves for the consumption of NADPH in the reduction of
dihydrofolate into tetrahydrofolate. (c): uncatalyzed NADPH degradation,
(····) split mDHFR system without DNA template, (a) split mDHFR system
with fully complementary template, and (–·–·–) full-length mDHFR. Insert
depicts the initial stage of the reaction.
Table 1. Initial rates for the reduction of dihydrofolate into tetrahydrofo-
late catalyzed by the split mDHFR system in the presence of different
concentrations of DNA template, and with DNA-template sequences con-
taining mismatches.[a]
Template Eq. template Initial rate [s1][b]
1 –[c] – 0.700.10







9 one mismatch 1 0.210.02
10 three mismatches 1 0.200.02
11 five mismatches 1 0.1370.009
12 no template – 0.0100.007[e]
[a] All experiments were performed in triplicate by using equimolar
amounts of protein–DNA conjugates and DNA templates at a final con-
centration of 0.1 mm, 100 mm dihydrofolate, and 100 mm NADPH in buffer
(50 mm Tris, pH 7.7, 5 mm MgCl2, 3.3 mm KCl, and 10 mm DTT) at 25 8C,
unless noted otherwise. [b] Calculated from the slope of the kinetic
curves at 340 nm. Calculation is based on 10% of the reaction, while dis-
carding the initial 15%, unless noted otherwise. Errors are calculated
from standard deviations. [c] 0.1 mm of full-length mDHFR. [d] Results cor-
respond to the average of two experiments. [e] The initial 15% of the
kinetic curve is discarded. Eq=Equivalent.
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HCl, 8m urea, as obtained from the final purification step from the
uncoupled oligonucleotide on the Ni–NTA column) was prepared.
NADPH (2 mL of 50 mm stock solution in MilliQ water) was added
to a dihydrofolate (H2F) solution (100 mm) in Tris-HCl buffer
(50 mm, pH 7.7, 5 mm MgCl2, 3.3 mm KCl, and 10 mm 1,4-dithio-
threitol (DTT)). The amount of buffer used corresponds to the nec-
essary volume to obtain a total reaction volume of 1 mL. The ex-
periment is initiated by the addition of the corresponding volume
of the premixed split mDHFR system solution to obtain a final con-
centration of 100 nm in the reaction mixture. Progress of the re-
action was monitored by following the decrease of the NADPH
absorption at 340 nm with UV–visible spectroscopy.
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